Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Drax Share Price
  4. Drax Share Regulatory News
  5. New £150 million term-loan facility

Pin to quick picksDrax Regulatory News (DRX)

Drax Information

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 565.00
Bid: 566.00
Ask: 567.00
Change: 14.00 (2.54%)
Spread: 1.00 (0.177%)
Open: 552.50
High: 568.00
Low: 550.00
Prev. Close: 551.00
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New £150 million term-loan facility

4 Apr 2024 07:00

RNS Number : 2379J
Drax Group PLC
04 April 2024
 

4 April 2024

Drax Group plc

("Drax"; Symbol: DRX)

 

New £150 million term-loan facility

 

Drax is pleased to announce that it has completed a new £150 million term-loan facility, comprised of an initial £125 million facility with an optional uncommitted extension of £25 million.

 

The facility, along with the undrawn £258 million term-loan facility signed in February 2024, will be used to refinance 2025 debt maturities.

 

These combined facilities have two tranches maturing in 2027(1) and 2029(2) and a customary margin referenced over SONIA (Sterling Overnight Index Average) for sterling loans and over EURIBOR (Euro Interbank Offered Rate) for euro loans.

 

Note

(1) 2027: €135 million and £145 million.

(2) 2029: €50 million and £80 million, with an optional uncommitted extension of £25 million.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Ali Lewis

+44 (0) 0771 267 0888

 

Website: www.drax.com

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAELDEFPLEAA
12345678910
Date   Source Headline
15th Feb 202410:51 amRNSHolding(s) in Company
13th Feb 202412:47 pmRNSHolding(s) in Company
7th Feb 202410:32 amRNSHolding(s) in Company
1st Feb 202411:56 amRNSTotal Voting Rights
31st Jan 20243:16 pmRNSHolding(s) in Company
30th Jan 20242:15 pmRNSHolding(s) in Company
30th Jan 20248:45 amRNSAdditional Listing
29th Jan 20243:02 pmRNSHolding(s) in Company
25th Jan 20249:37 amRNSHolding(s) in Company
23rd Jan 20243:43 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSBridging Mechanism Consultation
16th Jan 20249:25 amRNSHolding(s) in Company
12th Jan 20243:29 pmRNSHolding(s) in Company
10th Jan 20241:22 pmRNSHolding(s) in Company
2nd Jan 202412:50 pmRNSTotal Voting Rights
27th Dec 20234:59 pmRNSHolding(s) in Company
20th Dec 20231:13 pmRNSDevelopment of UK CCS and BECCS business model
18th Dec 20238:45 amRNSAdditional Listing
5th Dec 20234:10 pmRNSTotal Voting Rights
5th Dec 20237:00 amRNSTrading Update
30th Nov 202311:03 amRNSHolding(s) in Company
29th Nov 20233:28 pmRNSHolding(s) in Company
27th Nov 20234:32 pmRNSHolding(s) in Company
13th Nov 202312:10 pmRNSHolding(s) in Company
8th Nov 20234:17 pmRNSHolding(s) in Company
2nd Nov 202311:42 amRNSHolding(s) in Company
1st Nov 20239:42 amRNSTotal Voting Rights
30th Oct 20238:30 amRNSDirector/PDMR Shareholding
27th Oct 20232:21 pmRNSHolding(s) in Company
24th Oct 20234:53 pmRNSHolding(s) in Company
23rd Oct 202311:32 amRNSHolding(s) in Company
20th Oct 202311:51 amRNSHolding(s) in Company
19th Oct 20234:46 pmRNSHolding(s) in Company
13th Oct 20234:00 pmRNSHolding(s) in Company
5th Oct 20239:58 amRNSHolding(s) in Company
4th Oct 202310:11 amRNSBlock listing Interim Review
4th Oct 202310:07 amRNSBlock listing Interim Review
4th Oct 20239:59 amRNSBlock listing Interim Review
4th Oct 20239:57 amRNSBlock listing Interim Review
4th Oct 20239:44 amRNSHolding(s) in Company
3rd Oct 202310:05 amRNSTotal Voting Rights
28th Sep 20232:35 pmRNSDirector/PDMR Shareholding
28th Sep 20238:30 amRNSAdditional Listing
26th Sep 20235:29 pmRNSHolding(s) in Company
26th Sep 20231:30 pmRNSDirector/PDMR Shareholding
26th Sep 202312:44 pmRNSDirector/PDMR Shareholding
26th Sep 20237:25 amRNSTrack-1 expansion process update
22nd Sep 20233:41 pmRNSHolding(s) in Company
20th Sep 20234:14 pmRNSHolding(s) in Company
20th Sep 202311:43 amRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.